Sort   by:  
 Page size 
GenomicsKlebsiella phage KPP-1
Klebsiella phage KPP-X1 Genome sequencing and assembly
PRJNA1331516 | ENA
GenomicsAedes aegypti strain:KPP-TN
Aedes aegypti Transcriptome DENV1 CTRL/24hpi/96hpi
PRJNA386455 | ENA
UnknownCharacterization and biocontrol efficacy of lytic phage (KPP-1) that infects multidrug resistant Klebsiella variicola.
Not available
S-EPMC10484831 | biostudies-literature
UnknownCharacterization and Full Genome Sequence of Novel KPP-5 Lytic Phage against Klebsiella pneumoniae Responsible for Recalcitrant Infection.
Not available
S-EPMC8066614 | biostudies-literature
UnknownGenome Characterization of Bacteriophage KPP-1, a Novel Member in the Subfamily Vequintavirinae, and Use of Its Endolysin for the Lysis of Multidrug-Resistant Klebsiella variicola In Vitro.
Not available
S-EPMC9862379 | biostudies-literature
Genomicsmosquito metagenome strain:KPP Thai
Asaia spp. can accelerate development of the yellow fever mosquito, Aedes aegypti, via interactions with the vertically transmitted larval microbiome
PRJNA1054536 | ENA
ProteomicsPhosphoproteomics of mouse cardiomyocytes reveals signalling pathways triggered by a vasodilator cryptide
Animal venoms are natural sources of bioactive molecules such as cryptides that consist in biological active peptides released after proteolytic cleavage of a peptide or protein precursor. The KPP is a cryptided derived from the c-terminal of an hypotensin (TsHpI) a peptide isolated from the venom o...
ORGANISM(S): Mus musculus (Mouse) 
2020-07-06 | PXD015068 | Pride
Hipotensins Venome Scorpion Cryptide Cardiomyocytes Phosphopreteomics 
TranscriptomicsnCounter Mouse Inflammation (V2) Panel on Muscle from Cancer Cachexia Models
Mice were eithier injected with LLC or C26 cells, or injected with tamoxifen to indcue pancratic cancer in the KPP model. Matched controls were injected with PBS to mimic cell injections and control mice were injected with tamoxifen as controls for KPP.
ORGANISM(S): Mus musculus 
2024-08-01 | GSE245208 | GEO
TranscriptomicsModeling Human Cancer-induced Cachexia (Mouse)
Cachexia is a wasting syndrome characterized by pronounced skeletal muscle loss. In cancer, cachexia associates with increased morbidity and mortality and decreased treatment tolerance. Although advances have been made in understanding the mechanisms of cachexia, translating these advances to the cl...
ORGANISM(S): Mus musculus 
2019-08-06 | GSE133524 | GEO
TranscriptomicsModeling Human Cancer-induced Cachexia (Human)
Cachexia is a wasting syndrome characterized by pronounced skeletal muscle loss. In cancer, cachexia associates with increased morbidity and mortality and decreased treatment tolerance. Although advances have been made in understanding the mechanisms of cachexia, translating these advances to the cl...
ORGANISM(S): Homo sapiens 
2019-08-06 | GSE133523 | GEO
Sort   by:  
 Page size